The saline suppression test is a confirmatory diagnostic procedure used to determine whether a person’s body is producing too much aldosterone, the hormone responsible for regulating sodium and potassium balance. It works on a straightforward principle: pumping a large volume of salt water into the bloodstream should, in a healthy person, cause aldosterone levels to drop sharply. When they don’t drop, it suggests the adrenal glands are producing aldosterone on their own, independent of normal regulatory signals, pointing toward a condition called primary aldosteronism. The test has been a mainstay of endocrine diagnosis for decades, though the science around how to perform it, what cutoffs to use, and whether it’s even still necessary is evolving faster than many clinicians realize.
Why Confirmatory Testing Exists
Primary aldosteronism is the most common hormonal cause of high blood pressure. Screening for it typically starts with a blood test that measures the ratio of aldosterone to renin, two hormones that work in tandem to regulate blood pressure and fluid balance. A high ratio raises suspicion, but it isn’t proof. Many things can temporarily push that ratio up, including medications, stress, time of day, and even body position. Because a false diagnosis could lead a patient toward unnecessary surgery or lifelong medication changes, guidelines have historically required a second step: a confirmatory test that directly challenges the body’s aldosterone machinery.
The saline suppression test is one of several options for that second step. The logic is that flooding the body with sodium should suppress the renin-angiotensin pathway, which normally drives aldosterone production. If aldosterone stays stubbornly high despite this challenge, the adrenal glands are acting on their own.1The Journal of Clinical Endocrinology & Metabolism. Seated Saline Suppression Testing For The Diagnosis Of Primary Aldosteronism: A Preliminary Study In some cases with very strong screening results, like extremely low renin combined with aldosterone above 20 ng/dL and spontaneous low potassium, guidelines allow clinicians to skip confirmatory testing altogether and proceed directly to subtype evaluation.2PubMed Central. Sparing confirmatory testing in primary aldosteronism (SCIPA): a multicenter retrospective diagnostic accuracy study
How the Test Is Performed
The standard procedure involves infusing two liters of normal saline (0.9% sodium chloride) through a vein over four hours. Blood samples are drawn before the infusion begins and immediately after it ends, measuring aldosterone, renin, and sometimes cortisol. The test is typically done in the morning, since aldosterone levels follow a natural daily rhythm driven partly by the stress hormone ACTH. Patients are usually told to maintain a normal salt intake in the days leading up to the test, and certain medications need to be stopped or switched beforehand.
One detail that matters more than many patients and even some clinicians appreciate is body position. Traditionally, the test was done with the patient lying flat (the recumbent version). More recently, research has shown that performing the test with the patient seated dramatically improves its accuracy. A head-to-head comparison found the seated version had far better sensitivity for detecting primary aldosteronism, catching about 87% of true cases compared to just 38% for the recumbent version, while both had the same specificity of about 94%.3PubMed. Comparison of Seated With Recumbent Saline Suppression Testing for the Diagnosis of Primary Aldosteronism The seated version was especially better at identifying patients with bilateral disease, which is the most common subtype and the hardest to catch. If your center performs the test with you lying down, you should know the recumbent approach misses a substantial number of real cases.
Reading the Results
Interpretation hinges on a single question: how much aldosterone is left in the blood after four hours of saline loading? If the level drops below a threshold, primary aldosteronism is considered excluded. If it stays above the threshold, the diagnosis is confirmed. Between those extremes lies a gray zone where the result is inconclusive.
The specific cutoff numbers depend on whether the test was done seated or recumbent and which type of laboratory assay was used. For the seated version, research suggests a cutoff around 162 pmol/L (roughly 5.8 ng/dL) offers the best balance, correctly ruling out the condition in about 94% of people without it and correctly identifying roughly 96% of patients with surgically confirmed unilateral disease.3PubMed. Comparison of Seated With Recumbent Saline Suppression Testing for the Diagnosis of Primary Aldosteronism For the recumbent version, the optimal cutoff is lower (around 106 pmol/L), but even at this lower bar the test misses far more real cases. An earlier Chinese study using immunoassay found an optimal post-saline cutoff of about 11.2 ng/dL for their population, with over 90% sensitivity and 96% specificity.4The Journal of Clinical Endocrinology & Metabolism. Evaluation of the Saline Infusion Test and the Captopril Challenge Test in Chinese Patients With Primary Aldosteronism
These numbers look reassuring in isolation. The complication is that cutoffs validated at one center with one assay don’t always transfer cleanly to another center using different equipment, which is one reason different guidelines have historically quoted slightly different thresholds.
Why the Lab Method Matters Enormously
The way aldosterone is measured in the blood sample turns out to be one of the biggest sources of confusion in interpreting the saline suppression test. For decades, labs used immunoassays, a class of tests that rely on antibodies to detect aldosterone. These assays have a known weakness: they cross-react with other steroid molecules that look similar, leading to readings that are falsely high. Newer mass-spectrometry-based methods (LC-MS/MS) are far more precise, but they consistently produce lower aldosterone numbers, sometimes as much as 86% lower than immunoassay readings from the same blood sample.5PubMed Central. Aldosterone Levels Post-IV Saline Suppression Using Commercial Reference Laboratory Liquid Chromatography-Tandem Mass Spectrometry Assay
This discrepancy has real consequences. A study examining patients who had both immunoassay and mass-spectrometry measurements found that about a third had discordant results, meaning one method said they had primary aldosteronism while the other said they didn’t. Among patients with discordant results, only about 19% showed evidence of one-sided disease on further testing, compared to 78% of patients whose results agreed across both methods.6PubMed Central. The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay Inaccuracy In practical terms, the old immunoassay cutoffs don’t work with the newer, more accurate assays. Using mass spectrometry, confirmed primary aldosteronism cases showed median post-saline aldosterone levels of about 11.5 ng/dL, while people without the condition had median levels of just 1.0 ng/dL, with none exceeding 3.0 ng/dL.5PubMed Central. Aldosterone Levels Post-IV Saline Suppression Using Commercial Reference Laboratory Liquid Chromatography-Tandem Mass Spectrometry Assay If your lab is using mass spectrometry, the cutoff thresholds from older immunoassay-based studies will be misleadingly high.
Medications, Potassium, and Other Confounders
Several factors can distort test results in ways that lead to misdiagnosis in either direction. Medications are the most common culprit. Beta-blockers and centrally acting drugs like clonidine or methyldopa suppress renin while raising aldosterone, which can produce false-positive screening results and potentially affect confirmatory testing too.7PubMed Central. The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism Standard protocols require washing out drugs that directly interfere with the renin-angiotensin-aldosterone system, including ACE inhibitors, angiotensin receptor blockers, diuretics, and mineralocorticoid receptor antagonists like spironolactone, for at least two weeks before the test. Blood pressure is managed during this washout with less interfering drugs, typically calcium channel blockers or alpha-blockers.8The Journal of Clinical Endocrinology & Metabolism. The Spectrum of Dysregulated Aldosterone Production: An International Human Physiology Study
Low potassium is a subtler but equally important problem. Potassium is a direct stimulator of aldosterone secretion, so when potassium is low, aldosterone levels drop as well. This creates a paradox: many people with primary aldosteronism develop low potassium as a result of the disease, and that very low potassium then masks the elevated aldosterone the test is trying to detect. Some patients who initially test negative on the saline suppression test turn out to have primary aldosteronism after their potassium is corrected to at least 4 mEq/L and the test is repeated, yielding markedly different and higher aldosterone values.9The Journal of Clinical Endocrinology & Metabolism. Letter to the Editor: Comparison of Seated With Recumbent Saline Suppression Testing for the Diagnosis of Primary Aldosteronism
A third confounder is ACTH, the pituitary hormone that stimulates cortisol and, to a lesser extent, aldosterone. Because ACTH follows a strong morning-to-afternoon decline, its levels can shift during the four hours of the test. If ACTH rises unexpectedly (due to stress, pain from the IV, or simply irregular timing), it can keep aldosterone elevated even in someone who doesn’t have primary aldosteronism, producing an inconclusive or falsely positive result.3PubMed. Comparison of Seated With Recumbent Saline Suppression Testing for the Diagnosis of Primary Aldosteronism
How It Stacks Up Against Other Confirmatory Tests
The saline suppression test is not the only way to confirm primary aldosteronism. Three main alternatives exist, and each has trade-offs worth understanding.
The fludrocortisone suppression test is often considered the most rigorous option. It involves four days of oral fludrocortisone (a synthetic mineralocorticoid) combined with salt loading, with blood drawn on the final morning. A comparison between the two tests found that the saline infusion produced stronger aldosterone suppression than fludrocortisone, meaning a lower cutoff should be used for the saline test to avoid missing real cases.10PubMed. Comparison of the saline infusion test and the fludrocortisone suppression test for the diagnosis of primary aldosteronism The fludrocortisone test is logistically demanding, though, requiring hospitalization or at minimum very close outpatient monitoring over several days. Most centers have moved away from it for practical reasons.
The oral sodium loading test asks patients to eat a high-salt diet for three days and then collects a 24-hour urine sample. A recent comparison found that oral sodium loading caught more cases than the seated saline infusion test, with a sensitivity of about 85% versus 64%, while both had perfect specificity. The agreement between the two tests was only about 66%, meaning a meaningful number of patients got different answers depending on which test was used.11PubMed Central. Oral Sodium Loading Test Is More Sensitive Than Seated Saline Infusion Test to Confirm Overt Primary Aldosteronism
The captopril challenge test works differently, using a drug that blocks the enzyme converting angiotensin I to angiotensin II, which should drop aldosterone. It has the advantage of being simple, requiring only a single oral dose and blood draws at zero and two hours. In a large Chinese study, the captopril test slightly outperformed the saline infusion test, particularly in older patients.12PubMed Central. Comparison of saline infusion test and captopril challenge test in the diagnosis of Chinese with primary aldosteronism in different age groups Another Chinese study found the two tests performed comparably, with the saline infusion test showing a slightly higher area under the curve.4The Journal of Clinical Endocrinology & Metabolism. Evaluation of the Saline Infusion Test and the Captopril Challenge Test in Chinese Patients With Primary Aldosteronism The choice between tests often comes down to local expertise and patient factors rather than one being universally superior.
Using the Test to Predict Subtype
Once primary aldosteronism is confirmed, the next clinical question is whether the excess aldosterone comes from one adrenal gland (usually a small benign tumor called an aldosterone-producing adenoma) or from both glands (bilateral adrenal hyperplasia). This distinction matters because one-sided disease can be cured with surgery, while bilateral disease is managed with medication. The gold standard for telling them apart is adrenal vein sampling, an invasive catheterization procedure that isn’t available everywhere and isn’t always successful.
Interestingly, the saline suppression test itself may offer clues. Research has found that patients with bilateral disease tend to have lower post-test aldosterone levels and a larger drop in their aldosterone-to-renin ratio during the test compared to those with unilateral tumors. A combination of post-test aldosterone below 300 pmol/L and a falling aldosterone-to-renin ratio predicted bilateral disease with about 97% specificity, potentially allowing nearly half of bilateral patients to skip adrenal vein sampling.13PubMed. Saline suppression test parameters may predict bilateral subtypes of primary aldosteronism
A clinical prediction score combining age at diagnosis with saline test parameters pushed this further. Patients with aldosterone-producing adenomas tended to be younger (average age around 49 versus 57 for bilateral disease), had more suppressed renin before saline infusion, and had higher aldosterone after saline infusion. Scoring patients on age under 50, very low pre-infusion renin, and post-infusion aldosterone at or above 424 pmol/L produced a scoring system where meeting all three criteria predicted an adenoma with perfect specificity.14PubMed. A clinical prediction score using age at diagnosis and saline infusion test parameters can predict aldosterone-producing adenoma from idiopathic adrenal hyperplasia These tools are not yet standard practice, but they suggest the saline test contains more diagnostic information than just a binary positive-or-negative answer.
Growing Questions About Whether the Test Is Still Needed
Perhaps the most provocative recent development is a direct challenge to the premise of confirmatory testing. A prospective, blinded study measured post-saline aldosterone levels and then tracked whether patients actually responded to treatment targeted at primary aldosteronism (either surgery or mineralocorticoid receptor antagonists). The test could not meaningfully distinguish between patients who responded to treatment and those who didn’t. Post-test aldosterone concentrations overlapped substantially between the two groups, and likelihood ratios across a wide range of cutoffs were essentially equivocal.15PubMed. Confirmatory Testing for Primary Aldosteronism: A Study of Diagnostic Test Accuracy
This finding prompted a pointed editorial asking whether it’s time to retire aldosterone suppression testing from the diagnostic pathway altogether. The argument is that primary aldosteronism is common, underdiagnosed, and treatable, and that requiring a confirmatory test acts as a barrier to diagnosis. If the test doesn’t actually predict who benefits from treatment, the reasoning goes, it may be doing more harm than good by delaying or preventing diagnosis in people who would have been helped.16American Journal of Hypertension. Is It Time to Retire Aldosterone Suppression Testing? This view is not yet consensus, and many endocrinologists remain cautious about abandoning confirmatory testing entirely. But the direction of recent evidence is clear: the saline suppression test’s role in the diagnostic pathway is being questioned more seriously than at any point in its half-century history.
The Physiology Behind the Test
For those curious about what’s actually happening inside the body during those four hours of saline infusion, the mechanism was established in early physiological studies. As saline enters the bloodstream, blood volume expands and blood pressure at the kidney rises. This signals the kidney to cut production of renin, the enzyme that kicks off the hormonal cascade leading to aldosterone release. Classic experiments showed that renin and angiotensin II levels fell rapidly during saline infusion, dropping by half within the first hour and reaching their lowest point (70-80% below starting levels) by the end of six hours. Aldosterone followed the same downward pattern but with a slight lag, taking about 30 minutes before a meaningful decline was detectable.17Journal of Clinical Investigation. A Specific Role for Saline or the Sodium Ion in the Regulation of Renin and Aldosterone Secretion In primary aldosteronism, this suppression either fails completely or is markedly blunted because the adrenal glands are producing aldosterone through pathways that don’t depend on renin. Somatic mutations in genes like KCNJ5 and CACNA1D can drive autonomous aldosterone production in adrenal tumors, making them essentially deaf to the body’s normal “turn off” signals.18Trends in Endocrinology & Metabolism. Pathophysiology and histopathology of primary aldosteronism